RNA
Atrium TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
RNA vs peer average
40/100
RNA vs. peer average (D vs. C)
Grade spread
A 2 · B 2 · D 4 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
RNAC is the first available peer comparator.
Cartesian Therapeutics is only a loose small-cap biotech comp by size; it is not a close cardiology RNA delivery peer, which limits read-through.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
RNA
Atrium Therapeutics
RNAC
Cartesian Therapeutics
Grade
D
A
Momentum
18
89
Value
59
41
Sentiment
49
61
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs RNAC
RNA / RNAC
Grade Position
Below peers
RNA vs. peer average (D vs. C)
40/100
Momentum
18
RNACValue
59
RNASentiment
49
RNACRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs RNA
RNAC is the first peer returned for this comparison set.